Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Retinoic acid

N° du produit ABIN1027857

Aperçu rapide pour Retinoic acid (ABIN1027857)

  • Fonction

    Retinoid RAR agonist

    Attributs du produit

    Retinoid RAR agonist.

    Pureté

    >98 %

    Chemical Name

    Tretinoin, ATRA

    Formula

    C20H28O2

    Solubility

    Soluble to 50 mM in ethanol and 25 mM in DMSO
  • Commentaires

    Source: Synthetic.
    Appearance: Yellow solid

    Restrictions

    For Research Use only
  • Format

    Solid

    Précaution d'utilisation

    Classification: Toxic. May be harmful or fatal is inhaled, swallowed or absorbed through skin. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection Risk Phrases: R20/21/22 - Harmful by inhilation, in contact with skin and if swallowed R40 - Limited evidence of a carcinogenic effect R46 - May cause heritable genetic damage R62 - Possible risk of impaired fertility Hazard Phrases: H302-H411 Precautionary Phrases: P273

    Conseil sur la manipulation

    Classification: Toxic. May be harmful or fatal is inhaled, swallowed or absorbed through skin. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection Risk Phrases: R20/21/22 - Harmful by inhilation, in contact with skin and if swallowed R40 - Limited evidence of a carcinogenic effect R46 - May cause heritable genetic damage R62 - Possible risk of impaired fertility Hazard Phrases: H302-H411 Precautionary Phrases: P273

    Stock

    -20 °C
  • Sujet

    Retinoic acid is a metabolite of Vitamin A that mediates the functions of vitamin A required for growth and development. It is generated in a specific region of the embryo during early embryonic development.
    Synonyms: Tretinoin, ATRA

    Poids moléculaire

    300.44

    Numéro CAS

    302-79-4
Vous êtes ici:
Chat with us!